Trials / Completed
CompletedNCT01855256
Treatment of Hyperhidrosis With Oxybutynin
Treatment of Hyperhidrosis With Oxybutynin: a Randomized Controlled Double Blind Against Placebo
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the effectiveness of oxybutynin in hyperhidrosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxybutynin | Oxybutynin is started at a dose of 2.5 mg / day and increased gradually until an effective dose without exceed 7.5 mg / day up to 6 weeks. |
| DRUG | Placebo | Placebo is started at a dose of 2.5 mg / day and increased gradually until an effective dose without exceed 7.5 mg / day up to 6 weeks. |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-02-01
- Completion
- 2014-03-01
- First posted
- 2013-05-16
- Last updated
- 2025-12-03
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01855256. Inclusion in this directory is not an endorsement.